A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
Conditions
Diabetic Retinopathy · NPDR - Non Proliferative Diabetic Retinopathy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Retina-Vitreous Associates Medical Group, Beverly Hills, California, United States
Stanford Byers Eye Institute, Palo Alto, California, United States
California Retina Consultants- Santa Barbara, Santa Barbara, California, United States
Florida Retina Institute - Jacksonville Southside, Jacksonville, Florida, United States
Retina Associates, Elmhurst, Illinois, United States
Cumberland Valley Retina Consultants, Hagerstown, Maryland, United States
Erie Retina Research, Erie, Pennsylvania, United States
Piedmont Eye Center, Lynchburg, Virginia, United States
Eye Clinic Albury Wodonga, Albury, New South Wales, Australia
Retina And Eye Consultants Hurstville, Hurstville, New South Wales, Australia
Marsden Eye Specialists, Parramatta, New South Wales, Australia
Sydney Eye Hospital, Sydney, New South Wales, Australia
Sydney Retina Clinic, Sydney, New South Wales, Australia
Sydney West Retina, Westmead, New South Wales, Australia
University of the Sunshine Coast Clinical Trials (Birtinya), Birtinya, Queensland, Australia
Royal Adelaide Hospital, Adelaide, South Australia, Australia
Prince of Wales Hospital The Chinese University of Hong Kong, Shatin, Hong Kong
HKU Eye Centre, Wong Chuk Hang, Hong Kong
University Malaya Medical Centre, Petaling Jaya, Kuala Lumpur Federal Territory of Kuala Lumpur, Malaysia
Hospital Pulau Pinang, George Town, Pulau Pinang, Malaysia
Hospital Shah Alam, Shah Alam, Selangor, Malaysia
Hospital Al-sultan Abdullah Uitm, Sungai Buloh, Selangor, Malaysia
Hospital Selayang, Selayang Baru Utara, Malaysia
Seoul National University Bundang Hospital, Seongnam-si, South Korea
Asan Medical Center, Seoul, South Korea
Samsung Medical Center, Seoul, South Korea